Lung cancer is the leading cause of cancer death, and many patients do not respond to immunotherapy. Researchers from IBIMA Biomedical Research Institute of Málaga and...
Daiichi Sankyo presented new results on its DXd antibody-drug conjugates at WCLC25 in Barcelona, showcasing advances in small cell and non-small cell lung cancer. Highlights included...